HEADER TRANSFERASE 02-OCT-19 6SZE TITLE RIP2 KINASE CATALYTIC DOMAIN COMPLEX WITH 5-AMINO-1-PHENYLPYRAZOLE-4- TITLE 2 CARBOXAMIDE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.7.11.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS FRAGMENT BASED DRUG DESIGN (FBDD), RECEPTOR INTERACTING PROTEIN 2 KEYWDS 2 KINASE, RIPK2, RIP2K, RIP2, STRUCTURE BASED DRUG DESIGN (SBDD), KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.A.CONVERY,A.K.CHARNLEY,L.SHEWCHUK REVDAT 3 15-MAY-24 6SZE 1 REMARK REVDAT 2 04-DEC-19 6SZE 1 JRNL REVDAT 1 23-OCT-19 6SZE 0 JRNL AUTH C.D.HAFFNER,A.K.CHARNLEY,C.J.AQUINO,L.CASILLAS,M.A.CONVERY, JRNL AUTH 2 J.A.COX,M.A.ELBAN,N.C.GOODWIN,P.J.GOUGH,P.A.HAILE, JRNL AUTH 3 T.V.HUGHES,B.KNAPP-REED,C.KREATSOULAS,A.S.LAKDAWALA,H.LI, JRNL AUTH 4 Y.LIAN,D.LIPSHUTZ,J.F.MEHLMANN,M.OUELLETTE,J.ROMANO, JRNL AUTH 5 L.SHEWCHUK,A.SHU,B.J.VOTTA,H.ZHOU,J.BERTIN,R.W.MARQUIS JRNL TITL DISCOVERY OF PYRAZOLOCARBOXAMIDES AS POTENT AND SELECTIVE JRNL TITL 2 RECEPTOR INTERACTING PROTEIN 2 (RIP2) KINASE INHIBITORS. JRNL REF ACS MED.CHEM.LETT. V. 10 1518 2019 JRNL REFN ISSN 1948-5875 JRNL PMID 31749904 JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00141 REMARK 2 REMARK 2 RESOLUTION. 2.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 21429 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1154 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.94 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.02 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1539 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.64 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.3050 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4449 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 158 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.12000 REMARK 3 B22 (A**2) : 1.12000 REMARK 3 B33 (A**2) : -3.64000 REMARK 3 B12 (A**2) : 0.56000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.680 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.329 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.231 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.353 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.900 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4607 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6267 ; 1.546 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 543 ; 3.108 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 210 ;33.130 ;23.476 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 769 ;11.156 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ; 8.045 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 700 ; 0.110 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3526 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6SZE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-OCT-19. REMARK 100 THE DEPOSITION ID IS D_1292104603. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-SEP-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN A200 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22644 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.940 REMARK 200 RESOLUTION RANGE LOW (A) : 23.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.39700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM BUFFER (MES OR HEPES PH6.8-7.5), REMARK 280 12-28% PEG 400, 50-250MM CACL2, 0-200MM NACL, PH 7, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.38933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.69467 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 35.69467 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 71.38933 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 GLY A 3 REMARK 465 GLU A 4 REMARK 465 HIS A 50 REMARK 465 ILE A 51 REMARK 465 HIS A 52 REMARK 465 THR A 53 REMARK 465 PRO A 54 REMARK 465 LYS A 169 REMARK 465 TRP A 170 REMARK 465 ARG A 171 REMARK 465 MET A 172 REMARK 465 MET A 173 REMARK 465 SER A 174 REMARK 465 LEU A 175 REMARK 465 SER A 176 REMARK 465 GLN A 177 REMARK 465 SER A 178 REMARK 465 ARG A 179 REMARK 465 SER A 180 REMARK 465 SER A 181 REMARK 465 LYS A 182 REMARK 465 SER A 183 REMARK 465 ALA A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 GLY A 187 REMARK 465 GLY A 188 REMARK 465 PRO A 200 REMARK 465 GLY A 201 REMARK 465 GLN A 202 REMARK 465 LYS A 203 REMARK 465 SER A 204 REMARK 465 ARG A 205 REMARK 465 ALA A 206 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 ASN B 2 REMARK 465 GLY B 3 REMARK 465 GLU B 4 REMARK 465 GLY B 27 REMARK 465 ALA B 28 REMARK 465 SER B 29 REMARK 465 HIS B 50 REMARK 465 ILE B 51 REMARK 465 HIS B 52 REMARK 465 THR B 53 REMARK 465 PRO B 54 REMARK 465 LEU B 55 REMARK 465 ARG B 171 REMARK 465 MET B 172 REMARK 465 MET B 173 REMARK 465 SER B 174 REMARK 465 LEU B 175 REMARK 465 SER B 176 REMARK 465 GLN B 177 REMARK 465 SER B 178 REMARK 465 ARG B 179 REMARK 465 SER B 180 REMARK 465 SER B 181 REMARK 465 LYS B 182 REMARK 465 SER B 183 REMARK 465 ALA B 184 REMARK 465 PRO B 185 REMARK 465 GLY B 201 REMARK 465 GLN B 202 REMARK 465 LYS B 203 REMARK 465 SER B 204 REMARK 465 ARG B 205 REMARK 465 ALA B 206 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 26 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 55 CG CD1 CD2 REMARK 470 LEU A 56 CG CD1 CD2 REMARK 470 ASP A 57 CG OD1 OD2 REMARK 470 GLU A 59 CG CD OE1 OE2 REMARK 470 LYS A 61 CG CD CE NZ REMARK 470 ARG B 26 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 56 CG CD1 CD2 REMARK 470 ASP B 57 CG OD1 OD2 REMARK 470 GLU B 59 CG CD OE1 OE2 REMARK 470 GLU B 186 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 21 81.18 -64.86 REMARK 500 LEU A 24 -62.37 -129.66 REMARK 500 SER A 29 15.86 -172.05 REMARK 500 ASP A 57 -72.69 -62.89 REMARK 500 HIS A 145 -5.75 64.99 REMARK 500 ASP A 155 -167.46 -72.47 REMARK 500 LEU B 24 -57.71 -120.60 REMARK 500 GLU B 59 51.67 -91.23 REMARK 500 ALA B 73 30.00 -91.09 REMARK 500 HIS B 145 -2.91 56.85 REMARK 500 ASP B 164 89.61 70.06 REMARK 500 TRP B 273 31.25 -91.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 585 DISTANCE = 5.85 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M2B A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CA B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M2B B 402 DBREF 6SZE A 1 310 UNP O43353 RIPK2_HUMAN 1 310 DBREF 6SZE B 1 310 UNP O43353 RIPK2_HUMAN 1 310 SEQADV 6SZE GLY A 0 UNP O43353 EXPRESSION TAG SEQADV 6SZE GLY B 0 UNP O43353 EXPRESSION TAG SEQRES 1 A 311 GLY MET ASN GLY GLU ALA ILE CYS SER ALA LEU PRO THR SEQRES 2 A 311 ILE PRO TYR HIS LYS LEU ALA ASP LEU ARG TYR LEU SER SEQRES 3 A 311 ARG GLY ALA SER GLY THR VAL SER SER ALA ARG HIS ALA SEQRES 4 A 311 ASP TRP ARG VAL GLN VAL ALA VAL LYS HIS LEU HIS ILE SEQRES 5 A 311 HIS THR PRO LEU LEU ASP SER GLU ARG LYS ASP VAL LEU SEQRES 6 A 311 ARG GLU ALA GLU ILE LEU HIS LYS ALA ARG PHE SER TYR SEQRES 7 A 311 ILE LEU PRO ILE LEU GLY ILE CYS ASN GLU PRO GLU PHE SEQRES 8 A 311 LEU GLY ILE VAL THR GLU TYR MET PRO ASN GLY SER LEU SEQRES 9 A 311 ASN GLU LEU LEU HIS ARG LYS THR GLU TYR PRO ASP VAL SEQRES 10 A 311 ALA TRP PRO LEU ARG PHE ARG ILE LEU HIS GLU ILE ALA SEQRES 11 A 311 LEU GLY VAL ASN TYR LEU HIS ASN MET THR PRO PRO LEU SEQRES 12 A 311 LEU HIS HIS ASP LEU LYS THR GLN ASN ILE LEU LEU ASP SEQRES 13 A 311 ASN GLU PHE HIS VAL LYS ILE ALA ASP PHE GLY LEU SER SEQRES 14 A 311 LYS TRP ARG MET MET SER LEU SER GLN SER ARG SER SER SEQRES 15 A 311 LYS SER ALA PRO GLU GLY GLY THR ILE ILE TYR MET PRO SEQRES 16 A 311 PRO GLU ASN TYR GLU PRO GLY GLN LYS SER ARG ALA SER SEQRES 17 A 311 ILE LYS HIS ASP ILE TYR SER TYR ALA VAL ILE THR TRP SEQRES 18 A 311 GLU VAL LEU SER ARG LYS GLN PRO PHE GLU ASP VAL THR SEQRES 19 A 311 ASN PRO LEU GLN ILE MET TYR SER VAL SER GLN GLY HIS SEQRES 20 A 311 ARG PRO VAL ILE ASN GLU GLU SER LEU PRO TYR ASP ILE SEQRES 21 A 311 PRO HIS ARG ALA ARG MET ILE SER LEU ILE GLU SER GLY SEQRES 22 A 311 TRP ALA GLN ASN PRO ASP GLU ARG PRO SER PHE LEU LYS SEQRES 23 A 311 CYS LEU ILE GLU LEU GLU PRO VAL LEU ARG THR PHE GLU SEQRES 24 A 311 GLU ILE THR PHE LEU GLU ALA VAL ILE GLN LEU LYS SEQRES 1 B 311 GLY MET ASN GLY GLU ALA ILE CYS SER ALA LEU PRO THR SEQRES 2 B 311 ILE PRO TYR HIS LYS LEU ALA ASP LEU ARG TYR LEU SER SEQRES 3 B 311 ARG GLY ALA SER GLY THR VAL SER SER ALA ARG HIS ALA SEQRES 4 B 311 ASP TRP ARG VAL GLN VAL ALA VAL LYS HIS LEU HIS ILE SEQRES 5 B 311 HIS THR PRO LEU LEU ASP SER GLU ARG LYS ASP VAL LEU SEQRES 6 B 311 ARG GLU ALA GLU ILE LEU HIS LYS ALA ARG PHE SER TYR SEQRES 7 B 311 ILE LEU PRO ILE LEU GLY ILE CYS ASN GLU PRO GLU PHE SEQRES 8 B 311 LEU GLY ILE VAL THR GLU TYR MET PRO ASN GLY SER LEU SEQRES 9 B 311 ASN GLU LEU LEU HIS ARG LYS THR GLU TYR PRO ASP VAL SEQRES 10 B 311 ALA TRP PRO LEU ARG PHE ARG ILE LEU HIS GLU ILE ALA SEQRES 11 B 311 LEU GLY VAL ASN TYR LEU HIS ASN MET THR PRO PRO LEU SEQRES 12 B 311 LEU HIS HIS ASP LEU LYS THR GLN ASN ILE LEU LEU ASP SEQRES 13 B 311 ASN GLU PHE HIS VAL LYS ILE ALA ASP PHE GLY LEU SER SEQRES 14 B 311 LYS TRP ARG MET MET SER LEU SER GLN SER ARG SER SER SEQRES 15 B 311 LYS SER ALA PRO GLU GLY GLY THR ILE ILE TYR MET PRO SEQRES 16 B 311 PRO GLU ASN TYR GLU PRO GLY GLN LYS SER ARG ALA SER SEQRES 17 B 311 ILE LYS HIS ASP ILE TYR SER TYR ALA VAL ILE THR TRP SEQRES 18 B 311 GLU VAL LEU SER ARG LYS GLN PRO PHE GLU ASP VAL THR SEQRES 19 B 311 ASN PRO LEU GLN ILE MET TYR SER VAL SER GLN GLY HIS SEQRES 20 B 311 ARG PRO VAL ILE ASN GLU GLU SER LEU PRO TYR ASP ILE SEQRES 21 B 311 PRO HIS ARG ALA ARG MET ILE SER LEU ILE GLU SER GLY SEQRES 22 B 311 TRP ALA GLN ASN PRO ASP GLU ARG PRO SER PHE LEU LYS SEQRES 23 B 311 CYS LEU ILE GLU LEU GLU PRO VAL LEU ARG THR PHE GLU SEQRES 24 B 311 GLU ILE THR PHE LEU GLU ALA VAL ILE GLN LEU LYS HET M2B A 401 15 HET CA B 401 1 HET M2B B 402 15 HETNAM M2B 5-AMINO-1-PHENYLPYRAZOLE-4-CARBOXAMIDE HETNAM CA CALCIUM ION FORMUL 3 M2B 2(C10 H10 N4 O) FORMUL 4 CA CA 2+ FORMUL 6 HOH *158(H2 O) HELIX 1 AA1 PRO A 14 HIS A 16 5 3 HELIX 2 AA2 SER A 58 ALA A 73 1 16 HELIX 3 AA3 SER A 102 ARG A 109 1 8 HELIX 4 AA4 ALA A 117 ASN A 137 1 21 HELIX 5 AA5 PRO A 194 TYR A 198 5 5 HELIX 6 AA6 LYS A 209 ARG A 225 1 17 HELIX 7 AA7 ASN A 234 GLN A 244 1 11 HELIX 8 AA8 HIS A 261 TRP A 273 1 13 HELIX 9 AA9 ASN A 276 ARG A 280 5 5 HELIX 10 AB1 SER A 282 THR A 296 1 15 HELIX 11 AB2 GLU A 298 GLN A 308 1 11 HELIX 12 AB3 PRO B 14 HIS B 16 5 3 HELIX 13 AB4 ARG B 60 ALA B 73 1 14 HELIX 14 AB5 SER B 102 ARG B 109 1 8 HELIX 15 AB6 ALA B 117 ASN B 137 1 21 HELIX 16 AB7 LYS B 148 GLN B 150 5 3 HELIX 17 AB8 PRO B 194 GLU B 199 5 6 HELIX 18 AB9 LYS B 209 ARG B 225 1 17 HELIX 19 AC1 ASN B 234 GLN B 244 1 11 HELIX 20 AC2 HIS B 261 TRP B 273 1 13 HELIX 21 AC3 ASN B 276 ARG B 280 5 5 HELIX 22 AC4 SER B 282 ARG B 295 1 14 HELIX 23 AC5 GLU B 298 LYS B 310 1 13 SHEET 1 AA1 2 CYS A 7 ALA A 9 0 SHEET 2 AA1 2 CYS B 7 ALA B 9 -1 O SER B 8 N SER A 8 SHEET 1 AA2 5 LEU A 18 ARG A 26 0 SHEET 2 AA2 5 THR A 31 HIS A 37 -1 O VAL A 32 N SER A 25 SHEET 3 AA2 5 GLN A 43 HIS A 48 -1 O VAL A 46 N SER A 33 SHEET 4 AA2 5 LEU A 91 GLU A 96 -1 O THR A 95 N ALA A 45 SHEET 5 AA2 5 ILE A 81 ASN A 86 -1 N LEU A 82 O VAL A 94 SHEET 1 AA3 2 ILE A 152 LEU A 154 0 SHEET 2 AA3 2 VAL A 160 ILE A 162 -1 O LYS A 161 N LEU A 153 SHEET 1 AA4 5 LEU B 18 SER B 25 0 SHEET 2 AA4 5 THR B 31 HIS B 37 -1 O VAL B 32 N SER B 25 SHEET 3 AA4 5 GLN B 43 HIS B 48 -1 O VAL B 46 N SER B 33 SHEET 4 AA4 5 LEU B 91 GLU B 96 -1 O THR B 95 N ALA B 45 SHEET 5 AA4 5 ILE B 81 ASN B 86 -1 N LEU B 82 O VAL B 94 SHEET 1 AA5 2 ILE B 152 LEU B 154 0 SHEET 2 AA5 2 VAL B 160 ILE B 162 -1 O LYS B 161 N LEU B 153 LINK O GLU B 112 CA CA B 401 1555 1555 2.35 CISPEP 1 THR A 139 PRO A 140 0 -1.35 CISPEP 2 THR B 139 PRO B 140 0 -0.07 SITE 1 AC1 11 LEU A 24 ALA A 45 LYS A 47 GLU A 66 SITE 2 AC1 11 LEU A 79 THR A 95 GLU A 96 TYR A 97 SITE 3 AC1 11 MET A 98 LEU A 153 HOH A 530 SITE 1 AC2 1 GLU B 112 SITE 1 AC3 11 LEU B 24 VAL B 32 ALA B 45 LYS B 47 SITE 2 AC3 11 LEU B 79 THR B 95 GLU B 96 TYR B 97 SITE 3 AC3 11 MET B 98 LEU B 153 HOH B 521 CRYST1 131.660 131.660 107.084 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007595 0.004385 0.000000 0.00000 SCALE2 0.000000 0.008770 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009338 0.00000